IGC Pharma, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
IGC Pharma, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q3 2024.
  • IGC Pharma, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $161K, a 38.8% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $161K -$102K -38.8% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $193K -$102K -34.6% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $198K -$128K -39.3% Mar 31, 2024 10-Q 2024-11-12
Q4 2023 $227K -$130K -36.4% Dec 31, 2023 10-Q 2024-02-14
Q3 2023 $263K -$124K -32% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $295K -$124K -29.6% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $326K -$124K -27.6% Mar 31, 2023 10-K 2024-06-24
Q4 2022 $357K -$125K -25.9% Dec 31, 2022 10-Q 2023-02-14
Q3 2022 $387K -$123K -24.1% Sep 30, 2022 10-Q 2022-11-01
Q2 2022 $419K -$119K -22.1% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 $450K -$38K -7.79% Mar 31, 2022 10-K 2023-07-07
Q4 2021 $482K -$28K -5.49% Dec 31, 2021 10-Q 2022-02-10
Q3 2021 $510K -$22K -4.14% Sep 30, 2021 10-Q 2021-10-29
Q2 2021 $538K -$15K -2.71% Jun 30, 2021 10-Q 2021-08-11
Q1 2021 $488K -$86K -15% Mar 31, 2021 10-K 2022-06-23
Q4 2020 $510K Dec 31, 2020 10-Q 2021-02-16
Q3 2020 $532K Sep 30, 2020 10-Q 2020-11-20
Q2 2020 $553K Jun 30, 2020 10-Q 2020-08-19
Q1 2020 $574K +$574K Mar 31, 2020 10-K 2021-06-14
Q1 2019 $0 Mar 31, 2019 10-K 2020-07-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.